Search & Analyze

Granules India Ltd.

HealthcarePharmaceuticals & Drugs

www.granulesindia.com BSE: 532482NSE: GRANULES

₹846.45BSE2.71%

16 Sep, 4:01 PM

₹846.45

₹20.71K Cr

31.26

4.23

14.13%

₹871.05

₹828.20

₹922.10

₹511.00

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,853.50	36.77	4,44,716.74	0.86	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,199.70	83.50	2,44,223.13	0.33	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,823.05	84.11	1,83,453.32	0.79	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,105.00	24.42	1,10,224.17	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,359.75	32.59	1,09,848.55	0.96	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,906.00	94.19	1,02,983.51	0.10	362.07	123.94%	2,026.31	29.10%	18.20
DR.REDDY'S DRREDDY	1,145.25	29.67	95,591.76	0.70	435.60	-69.10%	8,099.80	-5.51%	13.75
Granules India Ltd. GRANULES	846.45	31.26	20,707.15	0.21	179.96	59.77%	1,476.77	22.04%	15.74

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,179.87	966.62	1,137.70	1,197.43	1,210.11	1,296.99	1,387.94	1,470.61	1,476.77
Expenses	920.60	763.30	907.41	945.07	963.39	1,018.76	1,079.84	1,118.50	1,137.87
	259.27	203.32	230.29	252.36	246.71	278.23	308.10	352.10	338.91
	21.97%	21.03%	20.24%	21.07%	20.39%	21.45%	22.20%	23.94%	22.95%
	2.06	3.26	5.68	32.67	-9.57	-1.15	-3.64	24.69	2.27
Interest	27.02	25.67	26.57	23.98	23.78	29.19	28.69	32.69	21.12
	52.87	52.52	56.61	63.50	68.85	72.02	73.53	81.75	79.65
	181.44	128.38	152.79	197.55	144.53	175.87	202.23	262.36	240.40
	25.79%	24.26%	23.03%	23.04%	22.06%	25.74%	25.72%	23.17%	25.14%
	134.65	97.23	117.60	152.03	112.64	130.61	150.21	201.57	179.96
	5.56	4.01	4.85	6.27	4.64	5.38	6.19	8.13	7.26

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	3,764.92	4,511.92	6,550.27	7,450.74	10,021.61
	3,764.92	4,511.92	4,506.37	4,481.61	5,365.64
EXPENDITURE :
Increase/Decrease in Stock	-152.78	-45.37	-186.97	0.76	-224.08
Raw Material Consumed	2,036.42	2,352.65	2,208.22	1,724.94	2,099.78
Power & Fuel Cost	74.66	95.69	100.64	100.74	128.87
Employee Cost	366.44	420.35	550.24	619.66	849.14
Other Manufacturing Expenses	302.30	277.45	412.56	475.96	606.73
General and Administration Expenses	130.84	184.45	207.44	273.21	326.91
Selling and Distribution Expenses	247.45	280.00	290.63	297.79	333.41
Miscellaneous Expenses	37.96	33.39	67.62	43.32	59.75
	3,043.30	3,598.60	3,650.39	3,536.37	4,180.50
Operating Profit (Excl OI)	721.63	913.31	855.98	945.24	1,185.14
	18.22	14.29	4.40	12.92	20.33
	739.85	927.60	860.38	958.16	1,205.47
Interest	23.21	55.93	105.82	103.24	114.35
PBDT	716.63	871.67	754.56	854.92	1,091.12
	158.63	184.49	207.33	225.50	296.14
Profit Before Taxation & Exceptional Items	558.00	687.17	547.23	629.42	794.98
Exceptional Income / Expenses				30.75	-10.00
	558.00	687.17	547.23	660.17	784.98
Provision for Tax	145.24	170.58	141.92	158.65	189.96
	412.76	516.60	405.31	501.52	595.02
Extra items	0.00	0.00	0.00	0.00	0.00
Consolidated Net Profit	412.76	516.60	405.31	501.52	595.02
Profit Balance B/F	1,356.61	1,732.15	2,230.18	2,596.87	3,059.48
Appropriations	1,769.37	2,248.74	2,635.49	3,098.39	3,654.50
Equity Dividend %	150.00%	150.00%	150.00%	150.00%	175.00%
	16.64	21.34	16.72	20.68	24.01
Adjusted EPS	16.64	21.34	16.72	20.68	24.01

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	24.80	24.20	24.24	24.25	24.78
Share Warrants & Outstandings	16.72	18.02	18.30	13.71	365.63
Total Reserves	2,545.02	2,792.68	3,183.00	3,677.62	4,694.59
Reserve excluding Revaluation Reserve	2,545.02	2,792.68	3,183.00	3,677.62	4,694.59
	2,586.54	2,834.91	3,225.54	3,715.58	5,085.00
Minority Interest	0.56
Secured Loans	233.70	148.64	68.97	311.51	297.15
Deferred Tax Assets / Liabilities	12.54	6.22	-14.01	-36.47	-26.81
Other Long Term Liabilities	8.28	70.60	83.20	159.19	160.95
Long Term Provisions	28.31	29.26	37.88	31.76	47.79
Total Non-Current Liabilities	282.83	254.73	176.04	465.99	479.08
Trade Payables	638.61	782.13	749.53	726.07	672.80
Other Current Liabilities	200.85	193.19	261.08	304.61	336.07
Short Term Borrowings	765.58	810.88	1,054.24	922.56	1,025.34
Short Term Provisions	36.56	27.31	17.45	49.92	57.81
Total Current Liabilities	1,641.60	1,813.50	2,082.29	2,003.16	2,092.03
Total Liabilities	4,511.53	4,903.14	5,483.88	6,184.73	7,656.10
Gross Block	2,461.77	2,981.22	3,351.81	3,882.08	4,987.94
Less: Accumulated Depreciation	920.59	1,070.30	1,256.20	1,455.61	1,737.82
Net Block	1,541.17	1,910.92	2,095.62	2,426.47	3,250.12
Capital Work in Progress	311.92	228.04	259.54	436.95	406.49
Non Current Investments	19.67	21.21	21.52	22.04	0.84
Long Term Investment	19.67	21.21	21.52	22.04	0.84
Long Term Loans & Advances	89.47	157.48	190.00	179.51	226.32
Other Non Current Assets				1.04	1.64
Total Non-Current Assets	2,006.54	2,328.99	2,578.83	3,069.25	3,888.46
Inventories	978.55	1,149.41	1,300.55	1,342.82	1,673.03
Sundry Debtors	924.95	948.54	985.83	942.22	909.37
Cash and Bank	409.46	312.79	386.39	596.38	949.06
Other Current Assets	61.67	49.22	46.28	53.92	73.24
Short Term Loans and Advances	130.35	114.19	186.00	180.15	162.95
Total Current Assets	2,504.99	2,574.15	2,905.05	3,115.48	3,767.65
Net Current Assets (Including Current Investments)	863.39	760.65	822.76	1,112.32	1,675.62
Total Assets	4,511.53	4,903.14	5,483.88	6,184.73	7,656.10
Contingent Liabilities	0.99	3.04	3.04	3.04	0.93
Total Debt	1,092.76	1,058.62	1,223.23	1,285.79	1,338.13
	103.62	116.38	132.33	152.63	190.45
Adjusted Book Value	103.62	116.38	132.33	152.63	190.45

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	558.00	687.17	547.23	660.17	784.98
Adjustment	176.29	237.69	328.80	344.14	390.12
Changes In working Capital	-257.19	-10.31	-246.32	6.02	-141.66
Cash Flow after changes in Working Capital	477.11	914.55	629.71	1,010.32	1,033.45
Cash Flow from Operating Activities	332.06	738.75	439.41	866.57	793.25
Cash Flow from Investing Activities	-380.12	-191.36	-360.16	-691.29	-773.21
Cash Flow from Financing Activitie	190.00	-440.29	7.66	-92.51	379.29
Net Cash Inflow / Outflow	141.94	107.10	86.92	82.77	399.33
Opening Cash & Cash Equivalents	41.84	184.71	291.56	381.10	466.11
Cash & Cash Equivalent on Amalgamation / Take over / Merger					2.41
Effect of Foreign Exchange Fluctuations	0.94	-0.25	2.63	2.24	12.39
Closing Cash & Cash Equivalent	184.71	291.56	381.10	466.11	880.24

Ratios

Valuation

31.26

4.23

16.44

3.70

26.73

197.72

Profitability

14.13

15.74

8.60

11.83

5.94

Leverage & Liquidity

0.28

1.80

7.86

Returns

0.21

1.45

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	38.87	38.87	38.85	38.84	38.82	38.82	38.82	38.02	38.02
	34.51	34.34	35.44	37.59	36.77	32.01	31.03	32.32	33.61
	26.62	26.80	25.72	23.55	24.41	29.17	30.15	29.67	28.38
	61.13	61.13	61.15	61.16	61.18	61.18	61.18	61.98	61.98
No. of Shareholders	1,79,870	2,02,198	1,77,554	1,69,802	1,69,700	1,65,542	1,63,184	1,60,286	1,69,422

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-07-09	Board Meeting	Quarterly Results
2026-05-04	AGM
2026-04-29	Ex Dividend	Rs.1.7500 per share(175%)Final Dividend	2026-07-30	2026-07-30

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Granules India Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

13 members across the board and senior leadership

Chaitanya Tummala

Company Secretary & Compliance Officer

—

Krishna Prasad Chigurupati

Chairman & Managing Director

₹28.36 Cr

Mar '26

Priyanka Chigurupati

Executive Director

₹2.84 Cr

Mar '26

Harsha Chigurupati

Executive Director

₹2.84 Cr

Mar '26

Uma Devi Chigurupati

Executive Director

₹2.84 Cr

Mar '26

KB Sankar Rao

Non Independent & Non Executive Director

₹39.11 L

Mar '26

Kolli Basava Sankar Rao

Non Independent & Non Executive Director

₹29.10 L

Mar '25

Arun Sawhney